T. Rowe Price Associates’s Definitive Healthcare DH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98K | Buy |
24,921
+3,556
| +17% | +$14K | ﹤0.01% | 2894 |
|
|
2025
Q1 | $62K | Buy |
21,365
+793
| +4% | +$2.3K | ﹤0.01% | 2899 |
|
|
2024
Q4 | $85K | Buy |
20,572
+3,496
| +20% | +$14.4K | ﹤0.01% | 2856 |
|
|
2024
Q3 | $77K | Hold |
17,076
| – | – | ﹤0.01% | 2867 |
|
|
2024
Q2 | $94K | Buy |
17,076
+3,685
| +28% | +$20.3K | ﹤0.01% | 2768 |
|
|
2024
Q1 | $109K | Buy |
13,391
+1,387
| +12% | +$11.3K | ﹤0.01% | 2764 |
|
|
2023
Q4 | $120K | Buy |
12,004
+1,332
| +12% | +$13.3K | ﹤0.01% | 2685 |
|
|
2023
Q3 | $86K | Buy |
+10,672
| New | +$86K | ﹤0.01% | 2688 |
|
|
2022
Q3 | – | Sell |
-1,074,658
| Closed | -$24.6M | – | 2972 |
|
|
2022
Q2 | $24.6M | Buy |
1,074,658
+540,840
| +101% | +$12.4M | ﹤0.01% | 1117 |
|
|
2022
Q1 | $13.2M | Sell |
533,818
-762,087
| -59% | -$18.8M | ﹤0.01% | 1324 |
|
|
2021
Q4 | $35.4M | Buy |
1,295,905
+45,905
| +4% | +$1.25M | ﹤0.01% | 1120 |
|
|
2021
Q3 | $53.5M | Buy |
+1,250,000
| New | +$53.5M | 0.01% | 981 |
|